ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A multicenter, twelve-week treatment, single step titration, open-label study assessing the percentage of dyslipidemic high-risk patients achieving low density lipoprotein cholesterol (LDL-C) target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg

Trial Profile

ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A multicenter, twelve-week treatment, single step titration, open-label study assessing the percentage of dyslipidemic high-risk patients achieving low density lipoprotein cholesterol (LDL-C) target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top